Insight Health Expands Oncology Services Portfolio

Waldems-Esch – Insight Health GmbH is further expanding its data-driven offerings for the healthcare market. Coinciding with World Cancer Day, the company is launching Oncology Insights — a comprehensive portfolio of validated data, analytics, and technology solutions for market and healthcare research in oncology.

The incidence of oncological diseases continues to rise. With an aging population and evolving health risk factors, cancer is becoming an ever-greater challenge. Approximately one-third of the medications anticipated to enter the market in 2025 are intended for the treatment of various cancer types. In response to this trend, Insight Health is expanding its data resources in the area of compounding data and, with the new portfolio, is establishing a counterpart to its well-known offerings in finished medicinal products. This enables the company to provide broader market coverage, in-depth analytics, and advanced technology for data-driven oncology market insights — including solutions leveraging real-world medical data.

The medical shift toward personalized cancer therapies and increased differentiation among tumor entities demands more comprehensive real-world data and precise market segmentation in the pharmaceutical industry. With the expansion of its portfolio, the company is directly addressing this need. The new Oncology Insights provide a unique perspective on the oncology market, empowering clients to develop innovative treatment approaches in a targeted manner and to introduce them effectively into patient care.

“In line with our parent company CompuGroup Medical’s vision — that no one should suffer or die simply because, somewhere or at some point, essential medical information is missing — our Oncology Insights make the oncology data market even more accessible and transparent,” says Michael Hensoldt, Chief Executive Officer of Insight Health.

Oncology is considered one of the most promising markets in the pharmaceutical industry. Continuous advances across all areas of cancer therapy demand that every market player relies on data-driven strategies to effectively measure their market segments and optimize their positioning. Oncology Insights creates the ideal foundation for this, offering a unique data set and exceptional data quality.

Our enhanced database provides clients with a comprehensive view of the entire oncology statutory health insurance market volume. It includes prescription information for both finished pharmaceuticals and compounded formulations dispensed by retail and hospital outpatient pharmacies. In addition, the new Oncology Cockpit, part of the Oncology Insights portfolio, delivers an optimal overview of the key indicators in the oncology market. Of course, clients can also generate customized reports and analyses using our solutions and technologies, with the ability to visualize results automatically. For highly specific oncology market questions, Insight Health provides tailored analytics backed by medical expertise and real world medical data — including solutions for patient-level scenarios or sales force management.

“With Oncology Insights, we deliver the same commitment and trusted quality our clients have come to expect from Insight Health — earning an impressive 97 % customer satisfaction rating last year,” says Christian Bensing, Managing Director responsible for Marketing and Sales at Insight Health.

Insight Health will continue to strengthen and expand its commitment to the oncology market with additional innovative products and tailored solutions. “Our goal is to make a significant contribution to patient care in Germany through reliable and secure data,” explains Michael Hensoldt. Christian Bensing adds, “We are proud to continuously enhance our portfolio of services, empowering our clients to pursue sustainable, future-oriented medical care.”